-
Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation. The innovation involves lipid nanoparticles containing a high concentration of naproxen, which is gradually released into the affected joint to sustain the desired effect for up to 10 days without the need for repeated administration.
In an article published in the journal Scientific Reports, researchers [...]
-
Pruebas preclínicas muestran un efecto ampliado del medicamento y una disminución de efectos colaterales tales como ulceraciones estomacales. Esta innovación podría aplicarse en trastornos de la articulación temporomandibular (ATM), como la inflamación.
Merced a una nueva fórmula inyectable, científicos brasileños lograron aumentar la eficacia y el tiempo de acción de un medicamento que comúnmente se aplica en el [...]
-
Merced a una nueva fórmula inyectable, científicos brasileños lograron aumentar la eficacia y el tiempo de acción de un medicamento que comúnmente se aplica en el tratamiento de inflamaciones articulares. Esta innovación se vale de nanopartículas lipídicas con una alta concentración del principio activo, que se libera paulatinamente dentro de la articulación afectada. De este modo, se mantiene el efecto deseado durante hasta [...]
-
Merced a una nueva fórmula inyectable, científicos brasileños lograron aumentar la eficacia y el tiempo de acción de un medicamento que comúnmente se aplica en el tratamiento de inflamaciones articulares. Esta innovación se vale de nanopartículas lipídicas con una alta concentración del principio activo, que se libera paulatinamente dentro de la articulación afectada. De este modo, se mantiene el efecto deseado durante hasta [...]
-
C’est une première étude positive mené chez l’animal et ses résultats, présentés dans les Scientific Reports, devront encore être confirmés par des essais cliniques. Cependant, ces tests, menés par une équipe de la São Paulo Research Foundation (FAPESP) montrent une efficacité accrue du médicament ainsi que l'absence d'effets secondaires pour traiter l'inflammation des [...]
-
Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation.
The innovation involves lipid nanoparticles containing a high concentration of the active principle, which is gradually released into the affected joint to sustain the desired effect for up to ten days without the need for repeated administration of the drug.
In an article published in the journal [...]
-
Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation. The innovation involves lipid nanoparticles containing a high concentration of the active principle, which is gradually released into the affected joint to sustain the desired effect for up to ten days without the need for repeated administration of the drug.
In an article published in the journal [...]
-
Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation.
The innovation involves lipid nanoparticles containing a high concentration of the active principle, which is gradually released into the affected joint to sustain the desired effect for up to ten days without the need for repeated administration of the drug.
In an article published in the journal [...]
-
Pesquisadores brasileiros conseguiram prolongar o efeito do anti-inflamatório usado no tratamento de inflamações articulares, graças a uma nova fórmula asia injetável. A inovação envolve nanopartículas lipídicas contendo uma alta concentração do princípio ativo, que é Liberado paulatinamente dentro da articulação afetada mantendo o efeito desejado por até dez dias, sem [...]
-
Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation.
The innovation involves lipid nanoparticles containing a high concentration of the active principle, which is gradually released into the affected joint to sustain the desired effect for up to ten days without the need for repeated administration of the drug.
In an article published in the journal [...]
